rdf:type |
|
lifeskim:mentions |
umls-concept:C0007634,
umls-concept:C0009013,
umls-concept:C0018270,
umls-concept:C0033414,
umls-concept:C0039195,
umls-concept:C0086418,
umls-concept:C0229671,
umls-concept:C0332307,
umls-concept:C0439831,
umls-concept:C0449432,
umls-concept:C1179435,
umls-concept:C1524073,
umls-concept:C1548799,
umls-concept:C1705248
|
pubmed:issue |
2
|
pubmed:dateCreated |
1984-2-24
|
pubmed:abstractText |
Culture conditions are described that result in rapid expansion of cloned cytotoxic T cells of human origin. A combination of allogeneic lymphocytes and Epstein-Barr virus (EBV) transformed B cells (B-LCL) as irradiated feeder cells resulted in a 10-fold higher cell yield than obtained by use of either feeder cell alone. The large cell numbers obtained in a relatively short period of time facilitate in vitro and in vivo experimentation. Further enhancement of cell proliferation was obtained by the use of fresh human serum not heat-inactivated before use. This suggests the presence of a heat-labile growth stimulating factor or factors in human serum. Round-bottomed microtitre wells were found to give best culture results. Plating and harvesting of cells cultured in wells was facilitated by a specially designed culture flask. Addition of leucoagglutinin (purified phytohaemagglutinin) to the culture medium resulted in an approximately 3-fold higher cell yield. Optimal culture results were obtained when all the above factors were combined. It was possible to expand single cytotoxic T cells to up to 10(9) cells in about 30 days with full retention of cytolytic activity and target cell specificity. T cell clones have now been cultured for more than 70 generations.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-1759
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
10
|
pubmed:volume |
66
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
285-98
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:6197484-B-Lymphocytes,
pubmed-meshheading:6197484-Cell Communication,
pubmed-meshheading:6197484-Cell Division,
pubmed-meshheading:6197484-Cell Line,
pubmed-meshheading:6197484-Cell Transformation, Viral,
pubmed-meshheading:6197484-Clone Cells,
pubmed-meshheading:6197484-Culture Media,
pubmed-meshheading:6197484-Cytotoxicity, Immunologic,
pubmed-meshheading:6197484-Glycoproteins,
pubmed-meshheading:6197484-Hot Temperature,
pubmed-meshheading:6197484-Humans,
pubmed-meshheading:6197484-Immunologic Techniques,
pubmed-meshheading:6197484-Indomethacin,
pubmed-meshheading:6197484-Monocytes,
pubmed-meshheading:6197484-Phytohemagglutinins,
pubmed-meshheading:6197484-T-Lymphocytes, Cytotoxic,
pubmed-meshheading:6197484-Vitronectin
|
pubmed:year |
1984
|
pubmed:articleTitle |
Rapid expansion of human cytotoxic T cell clones: growth promotion by a heat-labile serum component and by various types of feeder cells.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|